Skip to content
Peptigraph home

Is CJC-1295 + Ipamorelin Legal? FDA, Compounding and WADA Status

CJC-1295 + Ipamorelin's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGHRH + GHRP blendUpdated
FDA status
Not approved
research blend
PCAC vote
Not reviewed
not on the Jul 2026 PCAC agenda
WADA
Prohibited (S2.2.4)
In and out of competition
Not legal adviceStatus reflects public FDA and WADA records on the date shown. Rules differ by country and state.

Current status

Not FDA approved · research blend

No. CJC-1295 + Ipamorelin is not FDA approved for any use.

CJC-1295 + Ipamorelin: regulatory status by country
CountryStatusSource
United StatesNot an approved productNot an approved product anywhere; see components (CJC-1295 (no DAC), Ipamorelin). Drugs@FDA (openFDA) search for the component CJC-1295 (no DAC) returned no matches on 2 Oct 2026.api.fda.govchecked 2 Oct 2026

Timeline

No FDA, advisory-committee or WADA action specific to CJC-1295 + Ipamorelin found in our records (checked 2 Oct 2026).
Every peptide on the FDA tracker

Compounding and research-use sellers

  • Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
  • The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
  • "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.

Sport and drug testing

Prohibited by WADA (S2.2.4)

Both components are named in S2.2.4 (CJC-1295 as a GHRH analogue, ipamorelin as a secretagogue), so the blend is prohibited at all times.

Outside the US

Rules differ by country. CJC-1295 + Ipamorelin is a pre-mixed blend, not an approved product. Status by country for each ingredient: CJC-1295, Ipamorelin.

No regulator record names the blend, so each half is read on its own

The FDA entry for CJC-1295 cites serious adverse events including increased heart rate and a systemic vasodilatory reaction.[3]

The FDA entry for ipamorelin cites unnatural amino acids that complicate peptide characterization.[3]

Ipamorelin acetate appears in FDA's safety-risk table for 503B bulk substances, with a September 2023 entry.[3]

Sport

WADA names CJC-1295 as a GHRH analogue, so a blend containing it falls under the prohibited list.[1]

Ipamorelin is named in the same WADA class, as a growth hormone secretagogue.[1]

Sellers

One FDA warning letter quotes a seller's product description for a blend of tesamorelin and ipamorelin; the cached letters do not quote a CJC-1295 and ipamorelin blend.[4]

Common questions

Is CJC-1295 ipamorelin FDA approved?

No Drugs@FDA record was returned for ipamorelin, and none for CJC-1295 either.[5]

Is CJC-1295 + Ipamorelin legal to buy?

It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.

Is CJC-1295 + Ipamorelin banned by WADA?

Yes. Prohibited by WADA (S2.2.4), in and out of competition.

Is CJC-1295 ipamorelin legal?

Under FDA's 503A rules, a pharmacy may compound only with bulk substances that meet set conditions. The cached FDA pages do not show either component as meeting them.[6]

Is CJC-1295 ipamorelin banned?

Yes, in sport. WADA names CJC-1295 as a GHRH analogue and ipamorelin as a growth hormone secretagogue.[1]

More on CJC-1295 + Ipamorelin

Sources

  1. 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  2. 2United States: Not an approved product anywhere; see components (CJC-1295 (no DAC), Ipamorelin). Drugs@FDA (openFDA) search for the component CJC-1295 (no DAC) returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  3. 3Official web pageOfficial web page · web page
  4. 4Official web pageOfficial web page · web page
  5. 5Drugs@FDA (openFDA) search: active ingredient "ipamorelin"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  6. 6Official web pageOfficial web page · web page

Found an error? Report a correction.